Imbruvica-Venclexta Combination Demonstrates Benefits in Untreated CLL
Results from a four-year follow-up of a phase 3 trial determined that the combination of Imbruvica and Venclexta provided benefits for untreated patients with CLL.
Depression Can Impact Breast Cancer Treatment and Survival
Depression reduces the likelihood of receiving recommend treatment, which can affect survival, according to a Kentucky-based study of patients with breast cancer.
